ClinicalTrialsFinder

Acquired Amegakaryocytic Thrombocytopenia Clinical Trials in Minneapolis, Minnesota

1 recruitingMinneapolis, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 2

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Severe Aplastic AnemiaAcquired Amegakaryocytic ThrombocytopeniaAcquired Pure Red Cell Aplasia+1 more
Masonic Cancer Center, University of Minnesota60 enrolled1 locationNCT06412497